title: Involvement of Fc epsilon RII/CD23 and L-arginine dependent pathway in IgE-mediated activation of human eosinophils.
abstract: Eosinophils display various receptors for immunoglobulin E (IgE) including the high affinity receptor for IgE (Fc epsilon RI), CD23 (Fc epsilon RII), and Mac-2/epsilon BP. We attempted here to clarify the role of these receptors in IgE-mediated activation of eosinophils from normal human bone marrow cultures. Pretreatment of eosinophils with IL-4 is required for IgE/anti-IgE-mediated stimulation of TNF-alpha and peroxydes production. TNF-alpha release from eosinophils was also induced following ligation of CD23 and to a lesser extent with anti-Mac-2, while Fc epsilon RI-ligation had no effect. IgE/anti-IgE effect dramatically decreased when eosinophils were pretreated with Fab fragments of CD23-mAb. In addition, this effect could also be reversed by inhibiting CD23-dependent nitric oxide pathway by NG-monomethyl-L-arginine. Nitric oxide chemical donor, SIN-1, induced TNF-alpha release from eosinophils. CD23 and nitric oxide pathway are thus involved in IgE-mediated stimulation of normodense human eosinophils.
authors.affiliation: Groupe d'Immuno-Hématologie Moléculaire, CNRS URA625, CHU Pitié-Salpêtrière, Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Arock
authors.forename: L
authors.initials: L
authors.lastname: Le Goff
authors.forename: P A
authors.initials: PA
authors.lastname: Bécherel
authors.forename: B
authors.initials: B
authors.lastname: Dugas
authors.forename: P
authors.initials: P
authors.lastname: Debré
authors.forename: M D
authors.initials: MD
authors.lastname: Mossalayi
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology; D001120:Arginine / Q000031:analogs & derivatives* / Q000378:metabolism* / Q000494:pharmacology; D001854:Bone Marrow Cells; D002478:Cells, Cultured; D004797:Enzyme-Linked Immunosorbent Assay; D004804:Eosinophils / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007073:Immunoglobulin E / Q000494:pharmacology*; D007700:Kinetics; D008981:Molsidomine / Q000031:analogs & derivatives / Q000494:pharmacology; D010545:Peroxides / Q000378:metabolism; D017455:Receptors, IgE / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D013481:Superoxides / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*; D019323:omega-N-Methylarginine
chemical_list: D000911:Antibodies, Monoclonal; D000959:Antihypertensive Agents; D010545:Peroxides; D017455:Receptors, IgE; D014409:Tumor Necrosis Factor-alpha; D013481:Superoxides; D019323:omega-N-Methylarginine; D007073:Immunoglobulin E; C002385:linsidomine; D001120:Arginine; D008981:Molsidomine